252 related articles for article (PubMed ID: 36991138)
1. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
3. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
4. Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options.
Geng J; Guo Y; Xie M; Li Z; Wang P; Zhu D; Li J; Cui X
Cancer Med; 2023 May; 12(10):12000-12017. PubMed ID: 36999888
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
Shen KY; Chen BY; Gao WC
Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
8. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
[TBL] [Abstract][Full Text] [Related]
9. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
11. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
Li F; Niu Y; Zhao W; Yan C; Qi Y
Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
[TBL] [Abstract][Full Text] [Related]
16. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
18. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
Wang S; Cheng L; Jing F; Li G
BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
[TBL] [Abstract][Full Text] [Related]
19. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
20. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
